CME PLANNING COMMITTEE LIST IN THE DEPARTMENT OF MEDICINE

ALLAN B. SCHWARTZ, M.D.
Director, CME for the Dept. of Medicine
Dr. Allan B. Schwartz has a commercial relationship with OrthoBiotech, Watson, Keryx – research grant. Sanofi Novartis, Ortho – speaker’s bureau. Dr. Schwartz will support his presentation and clinical recommendations with the “best available evidence” from the medical literature.
Drexel University College of Medicine has no commercial support to disclose.

HOWARD EISEN, M.D.
Chief, Division of Cardiology
Dr. Howard Eisen has no commercial relationships to disclose
Drexel University College of Medicine has no commercial support to disclose.

BARBARA SIMON, M.D.
Asst. Professor of Medicine, Endocrinology
Dr. Barbara Simon has no commercial relationships to disclose
Drexel University College of Medicine has no commercial support to disclose.

JAMES REYNOLDS, M.D.
Chief, Division of Gastroenterology
Dr. James Reynolds has a commercial relationship with Astra Zeneca – research grant.
Dr. Reynolds will support his presentation and clinical recommendations with the “best available evidence” from the medical literature.
Drexel University College of Medicine has no commercial support to disclose.

ISADORE BRODSKY, M.D.
Chief, Division of Hematology and Oncology
Dr. Isadore Brodsky has no commercial relationships to disclose
Drexel University College of Medicine has no commercial support to disclose.

JEFFREY JACOBSON, M.D.
Chief, Division of HIV & AIDS Medicine/Infectious Diseases
Dr. Jeffrey Jacobson has no commercial relationships to disclose
Drexel University College of Medicine has no commercial support to disclose.

SANDRA P. LEVISON, M.D.
Chief, Division of Nephrology
Dr. Sandra P. Levison has no commercial relationships to disclose
Drexel University College of Medicine has no commercial support to disclose.

EDWARD SCHULMAN, M.D.
Chief, Division of Pulmonary Medicine
Dr. Edward Schulman has received grant/research support from CV Therapeutics, Sepracor Inc., Boehringer Ingelheim, Pfizer, Genentech, Novartis, Schering-Plough, Glaxo Smith Kline, Archemix and Celgene. Dr. Schulman is a consultant for Boehringer Ingelheim, Sepracor, Novartis, Genentech and Critical Care Therapeutics. Dr. Schulman participates on speakers’ bureaus for Genetech, Novartis, Boehringer Ingelheim, Pfizer, Merck, and GlaxoSmithKline. Dr. Schulman’s presentation will include unlabeled or investigational uses of commercial products. Dr. Schulman will support his presentation and clinical recommendations with the “best available evidence” from the medical literature, and he will refrain from making recommendations regarding products or services.
Drexel University College of Medicine has no commercial support to disclose.

CAROLYN O’CONNOR, M.D.
Chief, Division of Rheumatology
Dr. Carolyn O’Connor has no commercial relationships to disclose
Drexel University College of Medicine has no commercial support to disclose.

HOWARD MILLER, M.D.
Executive Vice Chairman, Department of Medicine
Dr. Howard Miller has no commercial relationships to disclose
Drexel University College of Medicine has no commercial support to disclose.

PAMELA CRILLEY, D.O.
Associate Professor, Hematology and Oncology
Dr. Pamela Crilley has no commercial relationships to disclose
Drexel University College of Medicine has no commercial support to disclose.

WILLIAM BERLINGER, M.D.
Associate Professor, General Internal Medicine
Dr. William Berlinger has no commercial relationships to disclose
Drexel University College of Medicine has no commercial support to disclose.

KATHERINE SHERIFF, M.D.
Associate Professor, Center for Women’s Health
Dr. Katherine Sheriff has a commercial relationship with Reliant Pharmaceuticals – speaker’s bureau. Dr. Sheriff will change her presentation to eliminate relevance to the products/services of my commercial interest. Dr. Sheriff will support her presentation and clinical recommendations with the “best available evidence” from the medical literature and will refrain from making recommendations regarding products or services.
Drexel University College of Medicine has no commercial support to disclose.